Clinical Evaluation of BÜHLMANN Fecal Pancreatic Elastase (fPELA) Tests in the Diagnosis of Exocrine Pancreatic Insufficiency (PEI)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 201
- 试验地点
- 1
- 主要终点
- Clinical Performance of BÜHLMANN fPELA assays in the diagnosis of PEI
研究概览
简要总结
The study shall determine the clinical performance of the BÜHLMANN fecal pancreatic elastase (fPELA) assays in the diagnosis of exocrine pancreatic insufficiency (PEI).
This is a observational and cross-sectional performance study. Specimens and clinical data are collected by a single study site.
Included are subjects for which pancreatic elastase testing was indicated due to a suspected exocrine pancreatic insufficiency and which were at least 18 years of age. Subjects which suffered from diarrhea (stool water content ≥ 75%) at the time of sample collection are excluded from the study.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •suspected exocrine pancreatic insufficiency
- •at least 18 years of age.
排除标准
- •diarrhea (stool water content ≥ 75%) at the time of sample collection
结局指标
主要结局
Clinical Performance of BÜHLMANN fPELA assays in the diagnosis of PEI
时间窗: December 2021
Diagnostic sensitivity and specificity of BÜHLMANN fPELA assays
次要结局
未报告次要终点
